Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson's Disease.

Parkinson's disease is the second leading neurodegenerative disease of aging. For over five decades, oral levodopa has been used to manage the progressive motor deficits that are the hallmark of the disease. However, individual dose requirements are…

Preview only. Read the full abstract at the source